Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in health. Braz. J. Pharm. Sci. 2020;56:e17836 . doi:10.1590/s2175-97902020000217836